DocWire News Editors

DocwireNews

<p>The Mediterranean diet was effective at reducing hepatic fat content (HFC) compared to a low-fat diet, according to a new analysis.<p>The new study <a href="https://www.journal-of-hepatology.eu/article/S0168-8278(19)30274-0/fulltext">published</a> in the <em>Journal of Hepatology</em> looked at whether HFC losses caused by dietary interventions were associated with specific visceral adipose tissue loss. The study population included 278 participants with abdominal obesity/dyslipidemia were randomly assigned to low-fat or Mediterranean/low-carbohydrate diet with and without physical activity. Abdominal fat depots were evaluated using MRI.</p><blockquote class="twitter-tweet" data-width="500" data-dnt="true">
<p lang="en" dir="ltr">In press | The Beneficial effects of <a href="https://twitter.com/hashtag/Mediterraneandiet?src=hash&amp;ref_src=twsrc%5Etfw">#Mediterraneandiet</a> over low-fat diet may be mediated by decreasing hepatic fat content<a href="https://t.co/g74y4sMCaE">https://t.co/g74y4sMCaE</a><a href="https://twitter.com/hashtag/fattyliver?src=hash&amp;ref_src=twsrc%5Etfw">#fattyliver</a> <a href="https://twitter.com/hashtag/liverdisease?src=hash&amp;ref_src=twsrc%5Etfw">#liverdisease</a> <a href="https://twitter.com/hashtag/lifestyle?src=hash&amp;ref_src=twsrc%5Etfw">#lifestyle</a></p>
<p>&mdash; Journal of Hepatology (@JHepatology) <a href="https://twitter.com/JHepatology/status/1127585973347307523?ref_src=twsrc%5Etfw">May 12, 2019</a></p>
</blockquote><p><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></p><p>The study period lasted 18 months. Average participant age was 48 years (88% men), with a mean <a href="https://www.docwirenews.com/cardiology/large-body-mass-afib-development/">body mass index</a> of 30.8 kg/m<sup>2</sup>; HFC=10.2%). The analysis showed that percentage HFC decreased after six and 18 months compared to baseline, and that a reduction in HFC was associated with decreased in visceral adipose tissue beyond weight loss. Percentage HFC was independently associated with reductions in serum gamma-glutamyl-transferase and alanine aminotransferase, circulating chemerin, and HbA1c (P&lt;0.05). The Mediterranean diet was associated with a significantly greater percentage decrease in HFC (P=0.036) compared to a low-fat diet, as well as improvements in cardiometabolic risk parameters (P&lt;0.05) after controlling for visceral adipose tissue loss. Although the Mediterranean diet was associated with greater decreases in triglycerides, triglyceride/HDL ratio, and cardiovascular risk score were attenuated when controlling for HFC changes.</p><p>&ldquo;High hepatic fat content is associated with metabolic syndrome, type two diabetes mellitus, and coronary heart disease,&rdquo; the researchers wrote in their abstract. &ldquo;In this 18-month intervention trial, Mediterranean/low-carbohydrate diet induced a greater decrease in hepatic fat content than low-fat <a href="https://www.docwirenews.com/docwire-pick/home-page-picks/mediterranean-diet-ranked-no-1/">diet</a>, and the beneficial health effects were beyond the favorable effects of visceral fat loss.&rdquo;</p><blockquote class="twitter-tweet" data-width="500" data-dnt="true">
<p lang="en" dir="ltr">We see this proven in studies over and over but the debate with fad diets continue apace. <a href="https://t.co/WdWPZRrHVl">https://t.co/WdWPZRrHVl</a></p>
<p>&mdash; Fatty Liver Foundation (@LiverSaver) <a href="https://twitter.com/LiverSaver/status/1127592139603566593?ref_src=twsrc%5Etfw">May 12, 2019</a></p>
</blockquote><p><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></p><blockquote class="twitter-tweet" data-width="500" data-dnt="true">
<p lang="en" dir="ltr">Med diet = good diet &#129382;&#129361;&#129372;&#129379; <a href="https://t.co/ntuHcBI66Y">https://t.co/ntuHcBI66Y</a></p>
<p>&mdash; Rui Castro (@RuiCastroHD) <a href="https://twitter.com/RuiCastroHD/status/1127859896001581057?ref_src=twsrc%5Etfw">May 13, 2019</a></p>
</blockquote><p><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></p><blockquote class="twitter-tweet" data-width="500" data-dnt="true">
<p lang="en" dir="ltr">additional evidence of the increasing use and impact of the Mediterranean diet on fatty liver <a href="https://twitter.com/hashtag/fattyliver?src=hash&amp;ref_src=twsrc%5Etfw">#fattyliver</a> <a href="https://t.co/ZWvRnOqDaR">https://t.co/ZWvRnOqDaR</a></p>
<p>&mdash; Neha D. Shah MPH, RD, CNSC, CHES (@nehagastrord) <a href="https://twitter.com/nehagastrord/status/1127923398879793152?ref_src=twsrc%5Etfw">May 13, 2019</a></p>
</blockquote><p><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></p><blockquote class="twitter-tweet" data-width="500" data-dnt="true">
<p lang="en" dir="ltr">So many great points in this study! <br>Here's one! </p>
<p>liver fat drives cvd risk factors independent of visceral abdominal fat!!</p>
<p>The Beneficial effects of Mediterranean diet over low-fat diet may be &hellip; <a href="https://t.co/GJAU6WjqGJ">https://t.co/GJAU6WjqGJ</a></p>
<p>&mdash; ramon issa (@DrRamonIssa) <a href="https://twitter.com/DrRamonIssa/status/1127381621454266368?ref_src=twsrc%5Etfw">May 12, 2019</a></p>
</blockquote><p><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></p></p>


James Tumlin, MD

Joel M. Topf, MD, FACP

Proteinuria Remission With Sparsentan in FSGS

NKF Spring Clinical Meetings 2025

Jordana Jampel

Glycan-Targeting Novel Vaccine Shows Promise for Vast Virus Protection

Infectious Disease

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Latest News

The Mediterranean Diet Helps Reduce Hepatic Fat: Study

Cardiology

The Mediterranean diet was effective at reducing hepatic fat content (HFC) compared to a low-fat diet, according to a new analysis. ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe